Literature DB >> 7539001

Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.

E A Pasyk1, J K Foskett.   

Abstract

Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), a plasma membrane-localized chloride channel. Some mutations in CFTR, including one which affects most patients (delta F508-CFTR), prevent CFTR from exiting the endoplasmic reticulum (ER) where it is synthesized. To examine whether normal and mutant CFTRs function as chloride channels when they reside in the ER, the patch clamp technique was used to measure currents in the outer membrane of nuclei isolated from mammalian cells expressing CFTR. Both delta F508-CFTR as well as CFTR were revealed to function as cAMP-regulated chloride channels in native ER membrane. These results represent the first demonstrations of functional activity of CFTR in the biosynthetic pathway and suggest that conformational changes in the mutant protein, although recognized by ER-retention mechanisms, do not necessarily affect CFTR chloride channel properties, which may have implications for pathophysiology and therapeutic interventions in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539001     DOI: 10.1074/jbc.270.21.12347

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites.

Authors:  T M Bradford; M J Gething; R Davey; J J Hopwood; D A Brooks
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

2.  The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle.

Authors:  S M Valenzuela; M Mazzanti; R Tonini; M R Qiu; K Warton; E A Musgrove; T J Campbell; S N Breit
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

Review 3.  Novel pharmacologic therapies for cystic fibrosis.

Authors:  P L Zeitlin
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

4.  Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator.

Authors:  X Xiong; A Bragin; J H Widdicombe; J Cohn; W R Skach
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif.

Authors:  Kim Estell; Gavin Braunstein; Torry Tucker; Karoly Varga; James F Collawn; Lisa M Schwiebert
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  4-Phenylbutyrate stimulates Hsp70 expression through the Elp2 component of elongator and STAT-3 in cystic fibrosis epithelial cells.

Authors:  Laurence Suaud; Katelyn Miller; Ashley E Panichelli; Rachel L Randell; Catherine M Marando; Ronald C Rubenstein
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

Review 7.  Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

8.  Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy.

Authors:  S Eskandari; E M Wright; M Kreman; D M Starace; G A Zampighi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 9.  Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

10.  Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder.

Authors:  Mark T Clunes; Richard C Boucher
Journal:  Drug Discov Today Dis Mech       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.